TMSB4X: A novel prognostic marker for non-small cell lung cancer.

Yang, Ze; Luo, Jihang; Zhang, Mengmei; Zhan, Meixiao; Bai, Yuju; Yang, Yi; Wang, Wei; Lu, Ligong

Yang, Ze; Luo, Jihang; Zhang, Mengmei; Zhan, Meixiao; Bai, Yuju; Yang, Yi; Wang, Wei; Lu, Ligong.

Afiliação

Yang Z; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, Guangdong, China.
Luo J; The Second Affiliated Hospital of Zunyi Medical University, Zun Yi, Gui Zhou, China.
Zhang M; Affiliated Hospital of Zunyi Medical University, Zun Yi, Gui Zhou, China.
Zhan M; Zunyi Medical and Pharmaceutical College, Zun Yi, Gui Zhou, China.
Bai Y; Guangdong Provincial Key Laboratory of Tumor Interventional Diagnosis and Treatment, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, Guangdong, China.
Yang Y; The Second Affiliated Hospital of Zunyi Medical University, Zun Yi, Gui Zhou, China.
Wang W; The Second Affiliated Hospital of Zunyi Medical University, Zun Yi, Gui Zhou, China.
Lu L; Department of Pulmonary and Critical Care Medicine, Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University), Zhuhai, Guangdong, China.

Heliyon ; 9(11): e21505, 2023 Nov.

Article em En | MEDLINE | ID: mdl-38027718

Palavras-chave

Dendritic cell; Immune microenvironment; NSCLC; Survival prognosis; TMSB4X

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Idioma: En Revista: Heliyon Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China